Natera, Inc, a global leader in cell-free DNA and genetic testing, and MyOme, a leading clinical whole genome analysis and polygenic risk modeling company,...
Natera, Inc., a global leader in cell-free DNA testing, announced earlier at the Canaccord Genuity 42nd Annual Growth Conference in Boston that the company...
Natera, Inc., a global leader in cell-free DNA testing, announced that it has received written confirmation from the CMS Molecular Diagnostics Services Program (MolDX)...
Natera, Inc., a global leader in cell-free DNA testing, announced the results of a large, real-world study confirming strong performance of its Prospera donor-derived...
Natera, Inc. , a leader in personalized genetic testing and diagnostics, announced the company, along with its collaborators, will present new data on Natera's...
